← Back to Search

Intraocular Lens

Hoya AF-1 IOL for Cataract

Phase 4
Waitlist Available
Research Sponsored by Innovative Medical
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights

Study Summary

The doctors participating in this study are looking to show improved vision with the HOYA AF-1 aspheric intraocular lens after cataract surgery. They will also study the use of Revital Vision (neuro-sensory testing) in providing the highest potential for improved vision.

Eligible Conditions
  • Cataract

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Measuring Ocular Dominance
Overall post surgical outcomes
Secondary outcome measures
Measuring visual acuities

Trial Design

2Treatment groups
Experimental Treatment
Group I: Revital VisionExperimental Treatment1 Intervention
Group II: Hoya AF-1 IOLExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

Innovative MedicalLead Sponsor
51 Previous Clinical Trials
2,608 Total Patients Enrolled
14 Trials studying Cataract
572 Patients Enrolled for Cataract

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~1 spots leftby Apr 2025